The Precision Peptide Company Inc.
PNGAF
$0.34
-$0.01-1.48%
OTC PK
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 59.58% | 57.84% | -449.35% | -100.81% | -59.10% |
| Total Depreciation and Amortization | -- | -- | 1.83% | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -92.24% | -65.44% | 5,401.61% | -- | -- |
| Change in Net Operating Assets | -880.61% | 109.49% | -183.31% | 341.33% | -2,317.95% |
| Cash from Operations | -46.71% | 61.45% | -4,063.06% | 93.22% | -200.00% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -197.71% | -81.93% | 159.23% | -203.16% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -197.71% | -81.93% | 189.92% | -99.69% | -- |
| Total Debt Issued | -- | -- | -- | -- | -200.00% |
| Total Debt Repaid | -- | -- | 78.58% | -391.72% | -- |
| Issuance of Common Stock | 6,396.50% | -- | -- | 200.67% | 192.16% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 6,360.54% | -92.40% | -87.69% | 207.88% | 180.47% |
| Foreign Exchange rate Adjustments | 87.63% | -447.37% | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 165.25% | 35.17% | -150.88% | 2,713.70% | -193.21% |